Propagenix
Rockville
About Propagenix
Propagenix is a healthcare technology platform developer that aims to provide individualized diagnostics and cell therapies to improve human health. The company's systems are used in advanced therapies in development to differentiate primary epithelial adult stem cells for use in tissue models for drug discovery and toxicology screening, allowing medical professionals to address the acute shortage of transplantable organs that require mature, functional epithelial tissues such as skin, airways, and kidneys.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Funding stage: M&A
- Last round: Grant (Jun 2017)
- Website: propagenix.com
- Phone: (240)713-3300
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/propagenix-180295 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.